Dual Incretin Co-Agonism Stimulates insulin secretion, suppresses glucagon, and reduces appetite via GLP-1 receptors
Based on a study conducted on 2,539 adults, after 12 weeks of Tirzepatide treatment, researchers categorized participants as "early responders" if they had lost at least 5% of their body weight, and as "slow responders" if they had lost less than 5% of their body weight
14 Zepbound should not be used with other tirzepatide products or any GLP-1 receptor agonist medicines
Room temperature stability is limited, and every hour above recommended storage temperature reduces the effective shelf life of your reconstituted tirzepatide
The same goes for compounded tirzepatide, although it may have a shorter shelf life , so always make sure to check the packaging or ask the compounding pharmacy for the exact expiration date
JAMA 318(15):14601470